Summary
This paper describes a case of haemophilia due to factor VIII inhibitors occurring in a 13-year-old boy suffering from an autoimmune disease. The patient had autoantibodies to factor VIII. The haemophilia was controlled by vincristine and steroids, but this regimen had to be discontinued because of side effects, whereupon the haemophilia recurred. Treatment with intravenous immunoglobulin (IgG i.v.) produced a slow rise in factor VIII, and the factor VIII inhibitors disappeared. Although factor VIII activity was raised for only a few months and factor VIII inhibitors reappeared, immunoglobulin treatment was continued and the patient remained remained free of clinical symptoms. The mechanism of action of treatment with IgG is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allain JP, Gaillandre A, Frommel D (1981) Acquired haemophilia: functional study of antibodies to factor. VIII. Thromb Haemost 45: 285–289
Allain JP, Croissant MP, Lerolle D, Houbouyan L, Zuzel M, Frommel D (1982) In vivo interactions of autoantibodies to factor VIII with the factor VIII complex. Thromb. Haemost 48: 142–145
Beck EA (1979) Hemmkörper (Antikörper) gegen Faktor VIII bei Hämophilie A. Ther Umsch 36: 326–329
Gawryl MS, Hoyer LW (1982) Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood 60: 1103–1109
Green D (1971) Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide. Blood 37: 381–387
Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45: 200–203
Hintz G, Schwerdtfeger R (1982) Unterschiedliche Proportionen von Faktor VIII- und Faktor VIII-Inhibitoren in ihren Antigen-antikörper-Komplexen. Blut 45: 395–406
Hultin MB, Shaprio SS, Bowman HS, Gill FM, Andrew AT, Martinez J, Eyster ME, Sherwood WC (1976) Immunosuppressive therapy of factor VIII inhibitors. Blood 48: 95–108
Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulins for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1128–1130
Imbach P, Jungi TW (1983) Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura. Blut 46: 117–124
Klein KG, Parkin JD, Madaras F (1976) Studies on an acquired inhibition of factor VIII induced by penicillin allergy. Clin exp Immunol 26: 155–161
Lee H, Tucker D, Allain JP (1979) Rapid isolation and purification of antibody to factor VIII by protein. A. Thromb Res 14: 925–930
Lorenzini JL, Allain JP, Chalopin JM, Rifle G, Devilliers E, Carli PM, Cortet P, Bonhomme J (1983) Anticorps antifacteur VIII au cours d'une maladie de Rosai-Dorfman. Nouv Rev Fr Hematol 25: 23–26
Margolius A, Dudley JR, Jackson P, Ratnoff OD (1961) Circulating anticoagulans: A study of 40 cases and a review of the literature. Medicine (Baltimore) 40: 145–202
Nakashima K, Miyahara T, Fujii S, Kaku K, Matsumoto N, Kaneko T (1982) Spontaneously acquired factor VIII inhibitor in a 7-year-old girl. Acta Haematol 68: 58–62
Reece EA, Fox HE, Rapoport F (1982) Factor VIII inhibitor: A cause of severe postpartum hemorrhage. Am J Obstet Gynecol 144: 985–987
Shapiro SS, Hultin M (1975) Acquired inhibitors to the blood coagulation factors. Semin Thromb Hemost 1: 336–385
Shapiro SS (1979) Antibodies to blood coagulation factors. Clin Hematol 8: 207–214
Spero JA, Lewis JH, Hasiba U (1981) Corticosteroid therapy for acquired F VIII: C inhibitors. Br J Haematol 48: 635–642
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gianella-Borradori, A., Hirt, A., Lüthy, A. et al. Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin. Blut 48, 403–407 (1984). https://doi.org/10.1007/BF00319972
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00319972